Distribution of Some Clinically Significant Blood Group Antigens Amongst Blood Donors at Nnamdi Azikiwe University Teaching Hospital Nnewi, Anambra State Nigeria- A Pilot Study

References

[1] Al-Riyami AZ, Daar S. Transfusion in haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman. Sultan Qaboos Univ Med J. 2018;18(1):e3–e12. https://doi.org/10.18295/squmj.2018.18.01.002

[2] Lotterman S, Sharma S. Blood transfusion [updated 2023 Jun 20]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK499824/

[3] Erhabor O, Erhabor T, Adias TC, Polycarp II. Distribution of clinically relevant blood group antigens among Nigerians and the management of rhesus D negative pregnancies: Implications for haemolytic disease of the foetus and newborn and haemolytic transfusion reactions. IntechOpen; 2021. https://doi.org/10.5772/intechopen.90372

[4] Enosolease ME, Bazuaye GN. Distribution of ABO and Rh-D blood groups in the Benin area of Niger-Delta: Implication for regional blood transfusion. Asian J Transfus Sci. 2008;2(1):3–5. https://doi.org/10.4103/0973-6247.39502

[5] Lamba DS, Kaur R, Basu S. Clinically significant minor blood group antigens amongst North Indian donor population. Adv Hematol. 2013;2013:215454. https://doi.org/10.1155/2013/215454

[6] Chou ST, Westhoff CM. The Rh and RhAG blood group systems. Immunohematology. 2010;26(4):177–185.

[7] Getu J, Fekadu U, Melatwork T. Assessment of minor blood group system antigens and their phenotype among voluntary blood donors in Ethiopian Blood and Tissue Bank Service, Addis Ababa, Ethiopia. Ethiop J Health Sci. 2023;33(5):816–820.

[8] Adewoyin A, Lee G, Adeyemo T, Awodu O. Rh and Kell blood group antigen prevalence in a multi-ethnic cohort in Nigeria: Implications for local transfusion service. Immunohematology. 2018;34:61–65. https://doi.org/10.21307/immunohematology-2018-011

[9] Idongesit SA, Archibong UH, Edeheudim DE. Prevalence and specificities of immune red cell antibodies in adult patients with sickle cell anaemia and blood donors in Uyo, South-South Nigeria: A case-control study. Saudi J Pathol Microbiol. 2022;7(11):421–427.

[10] Ayodeji OO, Nyong IC, Adams EE, Akinloye BO, Kosamat YA, Okolo CS. Prevalence of alloantibodies associated with haemolytic disease of the fetus and newborn in pregnant women at the Ekiti State University Teaching Hospital, Ado-Ekiti, Southwest Nigeria. Afr J Reprod Health. 2023;27(6s):70.

[11] Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria. Niger J Clin Pract. 2015;18(4):522–526.

[12] Evers D, Middelburg RA, de Haas M, Zalpuri S, de Vooght KMK, van de Kerkhof D, et al. Red-blood-cell alloimmunisation in relation to antigens’ exposure and their immunogenicity: A cohort study. Lancet Haematol. 2016;3(6):e284–e292.

[13] Amornrat VR, Piyapong S, Chalawan B, Ratchadaporn P, Ninnate J, Supawadee S. The prevalence, alloimmunization risk factors, antigenic exposure, and evaluation of antigen-matched red blood cells for thalassemia transfusions: A 10-year experience at a tertiary care hospital. Transfusion. 2019;59(1):177–184.

[14] Zwingerman R, Jain V, Hannon J, Zwingerman N, Clarke G. Alloimmune red blood cell antibodies: Prevalence and pathogenicity in a Canadian prenatal population. J Obstet Gynaecol Can. 2015;37(9):784–790.

[15] Thedsawad A, Taka O, Wanachiwanawin W. Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias. Hematology. 2019;24(1):208–214. https://doi.org/10.1080/16078454.2018.1549818

[16] Jeremiah ZA, Odumody C. Rh antigens and phenotype frequencies of the Ibibio, Efik, and Ibo ethnic nationalities in Calabar, Nigeria. Immunohematology. 2005;21:21–24.

[17] Bogui S, Dembele B, Sekongo Y, Abisse S, Konaté S, Sombo M. Phenotypic profile of Rh and Kell blood group systems among blood donors in Côte d’Ivoire, West Africa. J Blood Transfus. 2014;2014:309817.

[18] Alalshaikh M, Almalki Y, Hasanato R, Almomen A, Alsughayir A, Alabdullateef A, et al. Frequency of Rh and K antigens in blood donors in Riyadh. Hematol Transfus Cell Ther. 2022;44(4):555–559. https://doi.org/10.1016/j.htct.2021.03.003

[19] Serekara GC, Echonwere-Uwikor BE, Opara FA. Kell blood group antigen: Rare amongst Igbo descents in Nigeria. Arch Hematol Blood Dis. 2025;7(1):25–28.

[20] Serekara GC, Echonwere-Uwikor BE, Celestine JS. Frequency of Kell (K) blood group antigen amongst indigenes of Ikwerre ethnicity in Rivers State, Nigeria. SJMLS. 2025;10(1).

[21] Imoru M, Babangida S, Erhabor O, Mohammed H, Egeonu S. Distribution of ABO, rhesus phenotypes, and Kell blood group antigens among pregnant women of Lelna ethnic group in Kebbi State, Northwest Nigeria. J Hematol Allied Sci. 2025;5:66–71.

[22] Christian SG, Igbogi A. Prevalence of Kell (K) antigen amongst Ijaw descents in Bayelsa State. BJMLS. 2025;10(2):1–8.

[23] Nurudeen YO, Igbeneghu C, Oyeleke KO, Nassir SA. Assessing ABO and Kell blood group phenotypes and antigens in donated blood units at University College Hospital, Ibadan, Nigeria. Int Blood Res Rev. 2024;15(4):16–24.

[24] Buhari H, et al. Blood group antigens phenotype frequencies among pregnant women in Sokoto State, Nigeria. Int Blood Res Rev. 2022;13(4):134–140.

[25] Onyenekwe CC, et al. Occurrence of Kell blood group among individuals with ABO and Rh (D) blood groups in Awka and Asaba, Nigeria. Int J Biol Chem Sci. 2023;17(5):1797–1803.

[26] Lawicki S, Covin RB, Powers AA. The Kidd (JK) blood group system. Transfus Med Rev. 2017;31(3):165–172.

[27] Erhabor O, Hassan M, Alhaji YB, Yakubu A, Buhari H. Kidd blood group phenotypes among pregnant women in Sokoto, North Western Nigeria. Asian Pac J Trop Med. 2014;7S1:S111–S115. https://doi.org/10.1016/S1995-7645(14)60215-7

[28] Joseph E, Serekara GC, Baribefe K. The prevalence of Kidd, Lewis, ABO and RhD blood group systems in diabetic patients attending RSUTH. Annals of Innovation in Medicine. 2025;3(1).

[29] Jacob RB, Akah MN, Robinson-Mbato L, Christian SG, Olusola OA, Eze EM. Expression of Kidd, Rh-C, E, and D antigen among indigenes of Bonny Kingdom, Nigeria. J Blood Disord Transfus. 2022;13:492.

[30] M’baya B, Mfune T, Mogombo E, Mphalalo A, Ndhlovu D, Knight RC. The prevalence of red cell antigens and antibodies in Malawi. Transfus Med. 2010;20(3):196–199.

[31] Makroo RN, Bhatia A, Gupta R, Phillip J. Prevalence of Rh, Duffy, Kell, Kidd & MNSs blood group antigens in the Indian blood donor population. Indian J Med Res. 2013;137(3):521–526.

[32] Saleem M, Ibrahim M. Characterization of Rh and other blood group systems amongst the Maldivian blood donors. Med J Malaysia. 2013;68(5):393–396.

[33] Kuriri FA, Ahmed A, Alhumud F, Alanazi F, Abdalhabib EK. Frequency of Duffy, Kidd, Lewis, and Rh blood group antigens and phenotypes among donors in the Al-Ahsa region, Saudi Arabia. Clin Lab. 2024;70(7):1316.

[34] Bae CO, Kwon SS, Kim S. Investigation of blood group genotype prevalence in Korean population using large genomic databases. Sci Rep. 2023;13:15326.

[35] Neote K, Mak JY, Kolakowski LF, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: Identity with the red blood cell chemokine receptor. Blood. 1994;84(1):44–52.

[36] Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295(6):302–304.

[37] Gaji AM, Ogbenna A, Girei AI, Pindiga KM, Adamu S, Yuguda S, et al. Duffy red cell antigen phenotype among indigenous pregnant women attending antenatal clinic at Federal Teaching Hospital Gombe, Nigeria. Afr J Lab Haem Transf Sci. 2023;2(4):266–276.

[38] Verduin EP, Brand A, Schonewille H. Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review. Transfus Med Rev. 2012;26(4):342–353.e5.

@article{1718342,
      author = {Chilota Chibuife Efobi, Ugochinyere Jane Chilaka, IfeomaClare Ajuba; Emeka Paul Okwummuo, Obiageli Winifred Onwurah; Francis Ifediata, Uchenna Nicholas Nkemjika; Meghan Delaney},
      title = {Distribution of Some Clinically Significant Blood Group Antigens Amongst Blood Donors at Nnamdi Azikiwe University Teaching Hospital Nnewi, Anambra State Nigeria- A Pilot Study},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {4},
      pages = {2051-2060},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1718342.pdf},
      abstract = {Background: Red cell alloimmunization poses a challenge in multiply transfused patients, especially in the developing countries, where blood transfusion medicine is still at its rudimentary stages. This leads to blood transfusion reactions and suboptimal improvement of hemoglobin concentration following blood transfusion. Understudying the distribution of the clinically significant red cell antigens amongst blood donors may give an insight for mitigating blood transfusion reactions in the multiply transfused patients.
Aim: To determine the distribution of some clinically significant red cell antigens in blood donors so as to aid development of local red cell panels for antibody screening of multiply transfused patients.
Methods: This was a cross-sectional descriptive study where consenting blood group O donors were recruited and their red cells tested for K, C,c,E,e,JKa,JKb,Fya following the manufacturers’ protocol (QUOTIENT). AHG was used for testing for FYa antigen. Descriptive statistics were used to summarize demographic characteristics. P value of < 0.05 was statistically significant.
Results: A total of 68 donors were recruited for the study. Majority were males 60 (88.2%) and 44 (64.7%) were less than 30 years of age. The most prevalent red cell antigen was c (100%), followed by e 67 (98.5%). About a quarter had C 18 (26.5%) and E 17 (25.0%), while only 2(2.9%) donors had Fya. None of the donors had KEL1, JKa,and JKb antigens. There was no statistically significant association between gender and red cell antigen distribution.
Conclusion: This study shows a varied distribution of clinically significant red cell antigens in blood donors in Nigeria. There is need for more broad based and extensive red cell phenotyping studies to boost the information on red blood cell antigen expression obtained from this study. This will help in developing a local reagent red cell panel for antibody screening and identification especially for these multiply transfused patients, hence reducing hemolytic blood transfusion reactions by ensuring these patients are given appropriately matched blood.},
      keywords = {red cell antigens; blood donors; alloimmunization; multiply transfused patients},
      month = {October},
  }